Atlas Trials

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Clinical trial NCT06590428 · RECRUITING

Trial details

NCT number
NCT06590428
Sponsor
Albert Einstein College of Medicine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Start date
2026-04-07
Primary completion
2029-06-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.